Bo Teodor Aastrup

Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna.

TFS Trial Form Support AB provides clinical trial services. The firm operates as a clinical contract research organization. Its services include regulatory affairs, feasibility, global clinical operations, study and site coordination, patient recruitment services, clinical data management, edc systems, biostatistics, pharmacovigilance/safety, medical writing, quality assurance, tfs academy, and functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lund, Sweden.

SEED Capital Management I/S is an Independent Venture Capital firm founded in 2004. The company is headquartered in Copenhagen, Denmark.

Navamedic AB purchases and in-licenses pharmaceuticals and other healthcare products. Its commodities include drugs for: mouth and throat problems, dermatologic, urologic, gynecologic, cardiologic, and other disorders. The company was founded in 1999 and is headquartered in Molndal, Sweden.

Part of Abbott Laboratories, NeoPharma AB is a Swedish pharmaceutical preparation company. The company is based in Vastra Gotaland, Sweden. The company was founded by Sten-Magnus Aquilonius, Lars Christer Nyström.

Alkalon A/S engages in the development of pharmaceutical industry. It focuses on developing and commercializing medicated chewing gum formulations. The firm also owns portfolio of nicotine gums approved for smoking cessation and smoking reduction. The company was founded by Bo Tandrup in 2007 and is headquartered in Copenhagen, Denmark.

Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark.

Abilia Sverige Holding AB develops, manufactures, and trades assistive technology for persons with disabilities. The company is headquartered in Solna, Sweden.

Observe Medical ApS develops medical devices for digital monitoring of a patients’ urine output. Its brands include sippsense, sippcoat, sippbag, and sipplink. The company was founded on June 26, 2010 and is headquartered in Kongens Lyngby, Denmark.

Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden.

Observe Medical International AB develops medical technology products. It produces digital urine meters which measures biofilm build-up. The firm’s product Sippi is an automated digital urine measurement system which detects surface degradation and impending biofilm formation. The company was founded by Per Magnus Emmoth, Mikael Charléz and Mikael Löfgren and is headquartered in Gothenburg, Sweden.

LobSor Holding AB owns and manages shares and participations. The company is headquartered in Uppsala, Sweden.

Tridentify AB provides monitoring and quality assurance of blood bags. It products include the Tracer, the Access Point, the Check-in Node, the Web Portal and the Reader. The company was founded in 2009 by Petra Lindberg and Magnus Gramming and is headquartered in Gothenburg, Sweden.

MagCath ApS develops clinically tested and medical device which helps women suffering from severe stress incontinence. The company was founded by Neils Erikstrup and Rune Wetlesena and is headquartered in Copenhagen, Denmark.

Acarix A/S engages in development, production and advertisement of a new cardiovascular diagnostic methods and equipment. It develops engages in the non-invasive and non-radiation acoustic detection of coronary artery disease. The firm designs CADScor, a sensor that records, processes, and displays heart signal. The company was founded in 2009 and is headquartered in Kongens Lyngby, Denmark.

Part of Nidda Topco SARL, Lobsor Pharmaceuticals AB is a Swedish company that manufactures and wholesales pharmaceutical products. The company is based in Uppsala, Sweden. The company was founded by Ulf Rosén, who has been the CEO since incorporation. Lobsor Pharmaceuticals was acquired by STADA Arzneimittel AG, a subsidiary of Nidda Topco SARL from LobSor Holding AB on October 02, 2020.

Rosén Trading & Consulting Uppsala Ltd. is a private company based in Uppsala, Sweden. The Swedish company engages in trading goods and provides business consulting services.

Anian AB provides corporate consulting and securities brokerage services. The private company is based in Gronviksvagen, Sweden.

Ponscasa Holding AB is a Swedish company that manages real estate property and provides business consulting services. The private company is based in Uppsala, Sweden. The CEO of the company is Ulf Rosén.

Biotech Invest I Albano AB manages and sells fixed and movable property. The private company is based in Stockholm, Sweden.

VOC Diagnostics AB is a cancer diagnostics firm focusing on detection of ovarian cancer as a first indication. The company was founded by György Horvath in 2017 and is headquartered in Solna, Sweden.

InTrance Holding AB is an investment holding Swedish company. The company is based in Uppsala, Sweden. The company was founded in 2018 by Ulf Rosén.

Intrance Medical Systems, Inc. is a company focused on developing and commercializing clinical products for the treatment of advanced Parkinson's disease. The company is based in Albany, NY. Recently, the company appointed Ashley Prange as Vice President of Business Development to strengthen its focus on strategic partnerships, including out-licensing activities and commercial collaborations. Parkinson's disease is the second most common neurodegenerative disorder, affecting nearly one million people in the United States. The company was founded in 2018 by Ulf Rosén and Roger Bolsöy. The CEO is Patrick M. Shea.

AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021.

Rsq Capital operates as a venture capital firm. The private company is based in Stockholm, Sweden.

Cure Cancer Foundation operates as a cancer care foundation. The private company is based in Austin, TX.